When City Manager Aaron Busch attended his first Biotech International conference as a member of the city’s staff, he found ...

Presentation details ... beyond the standard-of-care regimen of existing checkpoint inhibitors. About MAIA Biotechnology, Inc. MAIA is a targeted therapy, immuno-oncology company focused on ...

The oral presentation also included discussion of ... About CyanVac and Blue Lake Biotechnology CyanVac LLC and its affiliate, Blue Lake Biotechnology, Inc., are developing intranasal vaccines ...

Although accepted as an oral presentation, NKGen has opted to showcase ... NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous ...

VALENCIA, Spain, Nov. 11, 2024 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage ... today announced an oral presentation at the upcoming TIDES Europe Annual Meeting, being held November ...

Although accepted as an oral presentation, NKGen has opted to showcase ... toward bringing this therapy to market. About NKGen Biotech NKGen is a clinical-stage biotechnology company focused ...

MAIA’s Chief Scientific Officer Sergei Gryaznov, Ph.D. commented, “Our presentation will demonstrate ... About MAIA Biotechnology, Inc. MAIA is a targeted therapy, immuno-oncology company ...

A copy of the poster will be added to the Scientific Publications page of the Company's website at once the presentation has ... NKGen is a clinical-stage biotechnology company focused on the ...

A copy of the poster will be added to the Scientific Publications page of the Company’s website at https://nkgenbiotech.com/ once the presentation has concluded ...